Apollo Silver Corp. (‘Apollo Silver’ or the ‘Company’) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF) is pleased to announce that it has upsized its previously announced non-brokered private placement by an additional $2,500,000, to…
-
-
Investing
Nine Mile Metals Announces Certified High-Grade Assay Results up to 15.00% Copper from the Wedge Project, Bathurst, New Brunswick
Nine Mile Metals LTD. (CSE: NINE,OTC:VMSXF) (OTC Pink: VMSXF) (FSE: KQ9) (the ‘Company’ or ‘Nine Mile’) is pleased to announce Certified Assay results for volcanogenic massive sulphide (VMS) mineralization collected…
-
Jeffrey Christian, managing partner at CPM Group, shares his outlook for gold and silver in 2026, explaining why he expects higher prices for the metals. ‘We think that 2026 is…
-
Don Durrett: Gold, Silver Price Targets and 15 ‘Must-Own’ Silver Stocks Kicking off the list in the fifth spot is Don Durrett of GoldStockData.com. In this January interview, Don shared…
-
Investing
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
VANCOUVER, BC / ACCESS Newswire / December 24, 2025 / Goldgroup Mining Inc. (‘Goldgroup‘ or the ‘Company‘) (TSX-V:GGA)(OTC:GGAZF). Further to the Company’s news release dated September 18, 2025, Goldgroup is…
-
-
(TheNewswire) December 24th, 2025 TheNewswire – Muskoka, Ontario Steadright Critical Minerals Inc. (CSE: SCM,OTC:SCMNF) (‘Steadright’ or the ‘Company’) Board of Directors has approved an additional 1,200,000 options at 0.28…
-
Trading resumes in: Company: Silverco Mining Ltd. TSX-Venture Symbol: SICO All Issues: Yes Resumption (ET): 9:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading…
-
Investing
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
Correction: The conversion price was incorrectly reported as .14/share. The correct price is .165/share Correction: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment Correction: The…
-
The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy tailwinds. This combination is setting the stage for a continued…